BridgeBio Pharma Preferred Securities out of Shareholders Equity (Quarterly) Insights

BridgeBio Pharma, Inc. (BBIO)

66.54 -1.77 (-2.59%) USD | NASDAQ | Feb 25, 16:00

66.00 -0.54 (-0.81%) After-Hours: 07:54

View Preferred Securities out of Shareholders Equity (Quarterly) for BBIO.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Preferred Securities out of Shareholders Equity (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Preferred Securities out of Shareholders Equity (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Preferred Securities out of Shareholders Equity (Quarterly) Benchmarks

Start Trial

Insmed, Inc.	--
Mirum Pharmaceuticals, Inc.	--
Cogent Biosciences, Inc.	--
Alnylam Pharmaceuticals, Inc.	--
Sarepta Therapeutics, Inc.	--